Deutsch English Français

Contact

EP1430133

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1430133

EP1430133 - A SOLUBLE TOLL-LIKE RECEPTOR [Right-click to bookmark this link]
Status	Patent revoked Status updated on 14.03.2014 Database last updated on 31.08.2024
Most recent event Tooltip	11.04.2014	Lapse of the patent in a contracting state New state(s): CH, LI	published on 14.05.2014 [2014/20]
Applicant(s)	For all designated states SOCIETE DES PRODUITS NESTLE S.A. Case postale 353 1800 Vevey / CH
	[2007/17]
Former [2004/26]	For all designated states SOCIETE DES PRODUITS NESTLE S.A. Case postale 353 1800 Vevey / CH
Inventor(s)	01 / SCHIFFRIN, Eduardo 17, chemin de Riant-Mont CH-1023 Crissier / CH
	02 / AFFOLTER, Michael 8, chemin de la Séchaude CH-1073 Savigny / CH
	03 / LABETA, Mario O. 70 Dartington Drive Cardiff, CF 23 8SA / GB
	[2004/26]
Representative(s)	Caen, Thierry Alain Cabinet Santarelli 14, avenue de la Grande Armée 75017 Paris / FR
	[N/P]
Former [2011/03]	Caen, Thierry Alain Cabinet Santarelli 14, avenue de la Grande Armée 75017 Paris / FR
Former [2011/02]	Caen, Thierry Alain, et al Cabinet Santarelli 14, avenue de la Grande Armée 75017 Paris / FR
Former [2009/43]	Corticchiato, Olivier, et al Nestec S.A. Avenue Nestlé 55 1800 Vevey / CH
Former [2006/50]	Dixon, Sarah, et al Nestec S.A. IP Group/Patent Avenue Nestlé 55 1800 Vevey / CH
Former [2005/08]	Becker Kurig Straus Patentanwälte Bavariastrasse 7 80336 München / DE
Former [2004/26]	Schneiter, Sorin Avenue Nestlé 55 1800 Vevey / CH
Application number, filing date	02777127.8	13.09.2002
	[2004/26]
	WO2002EP10410
Priority number, date	EP20010121698	17.09.2001 Original published format: EP 01121698
	[2004/26]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO03025015
	Date:	27.03.2003
	Language:	EN
	[2003/13]
	Type:	A2 Application without search report
	No.:	EP1430133
	Date:	23.06.2004
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 27.03.2003 takes the place of the publication of the European patent application.
	[2004/26]
	Type:	B1 Patent specification
	No.:	EP1430133
	Date:	25.04.2007
	Language:	EN
	[2007/17]
Search report(s)	International search report - published on:	EP	28.08.2003
Classification	IPC:	C12N15/12, C07K14/705, C07K16/28, C12N5/10, A61K38/17, // A61P1/00, A61P11/00, A61P17/00	[2004/26]
	CPC:	C07K14/705 (EP,US); A61P1/00 (EP); A61P11/00 (EP); A61P17/00 (EP); A61P29/00 (EP); A61P37/02 (EP); (+) A61P37/08 (EP); A61K38/00 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/26]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	EIN LÖSLICHER TOLL-ÄHNLICHER REZEPTOR	[2004/26]
	English:	A SOLUBLE TOLL-LIKE RECEPTOR	[2004/26]
	French:	MOLECULE REGULATRICE DU RECEPTEUR TOLL SOLUBLE	[2004/26]
Entry into regional phase	19.04.2004	National basic fee paid
	19.04.2004	Designation fee(s) paid
	19.04.2004	Examination fee paid
Examination procedure	11.04.2003	Request for preliminary examination filed International Preliminary Examining Authority: EP
	19.04.2004	Examination requested [2004/26]
	23.08.2004	Despatch of a communication from the examining division (Time limit: M06)
	09.02.2005	Reply to a communication from the examining division
	08.07.2005	Despatch of a communication from the examining division (Time limit: M08)
	28.02.2006	Reply to a communication from the examining division
	09.03.2006	Despatch of a communication from the examining division (Time limit: M04)
	19.07.2006	Reply to a communication from the examining division
	13.10.2006	Communication of intention to grant the patent
	23.02.2007	Fee for grant paid
	23.02.2007	Fee for publishing/printing paid
Opposition(s)	Opponent(s)	01 25.01.2008 09.04.2008 ADMISSIBLE N.V. Nutricia Eerste Stationsstraat 186 2712 HM Zoetermeer / NL Opponent's representative Nederlandsch Octrooibureau P.O. Box 29720 2502 LS The Hague / NL
		[N/P]
	Former [2013/32]
	Opponent(s)	01 25.01.2008 09.04.2008 ADMISSIBLE N.V. Nutricia Eerste Stationsstraat 186 2712 HM Zoetermeer / NL Opponent's representative Nederlandsch Octrooibureau P.O. Box 29720 2502 LS The Hague / NL
	Former [2011/03]
	Opponent(s)	01 25.01.2008 09.04.2008 ADMISSIBLE N.V. Nutricia Eerste Stationsstraat 186 2712 HM Zoetermeer / NL Opponent's representative Meekel, Arthur Augustinus P. Nederlandsch Octrooibureau P.O. Box 29720 2502 LS Den Haag / NL
	Former [2010/52]
	Opponent(s)	01 25.01.2008 09.04.2008 ADMISSIBLE N.V. Nutricia Eerste Stationsstraat 186 2712 HM Zoetermeer / NL Opponent's representative Caen, Thierry Alain Santarelli, 14 Avenue de la Grande Armée 75822 Paris Cedex 17 / FR
	Former [2008/10]
	Opponent(s)	01 25.01.2008 N.V. Nutricia Eerste Stationsstraat 186 2712 HM Zoetermeer / NL Opponent's representative Meekel, Arthur Augustinus P. Nederlandsch Octrooibureau P.O. Box 29720 2502 LS Den Haag / NL
	07.05.2008	Invitation to proprietor to file observations on the notice of opposition
	09.09.2008	Reply of patent proprietor to notice(s) of opposition
	26.01.2010	Date of oral proceedings
	26.03.2010	Despatch of interlocutory decision in opposition
	26.03.2010	Despatch of minutes of oral proceedings
	16.01.2014	Legal effect of revocation of patent [ N /P ]
	16.01.2014	Legal effect of revocation of patent [2014/16]
	12.02.2014	Despatch of communication that the patent will be revoked
Appeal following opposition	27.05.2010	Appeal received No. T1222/10
	22.07.2010	Statement of grounds filed
	16.01.2014	Result of appeal procedure: revocation of the patent
	16.01.2014	Date of oral proceedings
	23.01.2014	Minutes of the oral proceedings despatched
Fees paid	Renewal fee
	14.09.2004	Renewal fee patent year 03
	14.09.2005	Renewal fee patent year 04
	11.09.2006	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CH	25.04.2007
	CY	25.04.2007
	EE	25.04.2007
	LI	25.04.2007
	SK	25.04.2007
	BG	25.07.2007
	LU	13.09.2007
	MC	30.09.2007
	[2014/20]
Former [2009/38]	CY	25.04.2007
	EE	25.04.2007
	SK	25.04.2007
	BG	25.07.2007
	LU	13.09.2007
	MC	30.09.2007
Former [2009/34]	CY	25.04.2007
	EE	25.04.2007
	SK	25.04.2007
	BG	25.07.2007
	MC	30.09.2007
Former [2009/10]	EE	25.04.2007
	SK	25.04.2007
	BG	25.07.2007
	MC	30.09.2007
Former [2008/22]	SK	25.04.2007
	BG	25.07.2007
	MC	30.09.2007
Former [2008/13]	SK	25.04.2007
	BG	25.07.2007
Former [2008/09]	BG	25.07.2007
Cited in	International search	[X]EP0864585 (HAYASHIBARA BIOCHEM LAB [JP]) [X] 1,2,8,10-27 * the whole document *;
		[X]WO9937772 (IMMUNEX CORP [US], et al) [X] 1,2,8,10-27 * the whole document *;
		[X] - FLO T H ET AL, "Detection of soluble TLR2 in human serum samples by ELISA.", JOURNAL OF ENDOTOXIN RESEARCH, 6th Conference of the International Endotoxin Society;Paris, France; August 24-27, 2000, (2000), vol. 6, no. 2, ISSN 0968-0519, page 106, XP001052916 [X] 1-7,10 * the whole document *
		[X] - FILIPP DOMINIK ET AL, "Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, January 16, 2001, (20010116), vol. 98, no. 2, ISSN 0027-8424, pages 603 - 608, XP002187481 [X] 1-6,8-27 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.98.2.603
		[X] - LABETA MARIO O ET AL, "Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14.", JOURNAL OF EXPERIMENTAL MEDICINE, (20000515), vol. 191, no. 10, ISSN 0022-1007, pages 1807 - 1812, XP002187480 [X] 1-6,8-12,14-19,21-25,27 * the whole document * DOI: http://dx.doi.org/10.1084/jem.191.10.1807
		[X] - DU ET AL., "Analysis of Tlr4-mediated LPS signal transduction in macrophages by mutational modification of the receptor", BLOOD CELLS, MOLECULES AND DISEASES, (19991115), vol. 25, no. 6, pages 328 - 338, XP002183507 [X] 1-6,10-27 * the whole document * DOI: http://dx.doi.org/10.1006/bcmd.1999.0262
		[X] - XU YINGWU ET AL, "Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.", NATURE (LONDON), (2000), vol. 408, no. 6808, ISSN 0028-0836, pages 111 - 115, XP002183508 [X] 1,2,7,8,11-13 * the whole document * DOI: http://dx.doi.org/10.1038/35047056
		[X] - PRUITT JEFFREY H ET AL, "Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome.", BLOOD, (1996), vol. 87, no. 8, ISSN 0006-4971, pages 3282 - 3288, XP001041460 [X] 1,2,8,10 * the whole document *
		[A] - O'NEILL L A J ET AL, "The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense", IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (200005), vol. 21, no. 5, ISSN 0167-5699, pages 206 - 209, XP004198146 [A] 14-27 * page 209, column 1, paragraph 2 * DOI: http://dx.doi.org/10.1016/S0167-5699(00)01611-X
		[A] - MANTOVANI A ET AL, "Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines", TRENDS IN IMMUNOLOGY, ELSEVIER, CAMBRIDGE, GB, (20010601), vol. 22, no. 6, ISSN 1471-4906, pages 328 - 336, XP004249049 [A] * the whole document * DOI: http://dx.doi.org/10.1016/S1471-4906(01)01941-X
		[A] - KOLB A F, "The prospects of modifying the antimicrobial properties of milk", BIOTECHNOLOGY ADVANCES, ELSEVIER PUBLISHING, BARKING, GB, (200107), vol. 19, no. 4, ISSN 0734-9750, pages 299 - 316, XP004274975 [A] * the whole document * DOI: http://dx.doi.org/10.1016/S0734-9750(01)00069-6
	Examination	WO9920756

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p